Omicron: The new variant of concern needs preparedness, not panic
DOI:
https://doi.org/10.47203/IJCH.2022.v34i01.001Keywords:
variant of concern, SARS-CoV-2, coronavirus disease 2019, India, OmicronAbstract
SARS-CoV-2 continues to be a Public Health Emergency of International Concern. On November 26, the World Health Organization (WHO) labeled the omicron type as a covid-19 variant of concern, prompting travel restrictions, a rush to accelerate booster immunization programmes, and new attempts to address vaccination disparities. According to the WHO, omicron is a "very high" concern throughout the world, and preliminary research indicates that it may be a more transmissible type, leading to infection surges (1,2). The Indian government keeps a close eye on the issue and gives appropriate guidelines as needed.
Omicron threat will depend on its transmissibility, Virulence, and capacity to evade immunity in those previously vaccinated or infected. Even if the disease is milder, the rapid onslaught of the virus could overwhelm health care systems (doubling time of 2.5 days means 50X increase in 2 weeks) (3). We should ensure mitigation plans are in place to maintain essential health services and that necessary resources are in place to respond to potential surges.
Downloads
References
World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern [Internet]. 2021 [cited 2021 Dec 10]. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
https://doi.org/10.4414/smw.2021.w30120
World Health Organization. The first few X cases and contacts (FFX) investigation protocol for coronavirus disease 2019 (COVID-19), version 2.2 [Internet]. World Health Organization; 2020 [cited 2021 Dec 17]. Available from: https://www.who.int/publications/i/item/the-first-few-x-cases-and-contacts-(-ffx)-investigation-protocol-for-coronavirus-disease-2019-(-covid-19)-version-2.2
https://doi.org/10.18502/ijph.v49is1.3669
National Institute for Communicable Diseases. The Daily COVID-19 Effective Reproductive Number (R) in South Africa [Internet]. 2021 [cited 2021 Dec 9]. Available from: https://www.nicd.ac.za/wp-content/uploads/2021/12/COVID-19-Effective-Reproductive-Number-in-South-Africa-week-48.pdf
World Health Organization. WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply [Internet]. 2021 [cited 2021 Dec 10]. Available from: https://www.who.int/publications/i/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply
https://doi.org/10.1126/science.abf9634
World Health Organization. WHO advice for international traffic in relation to the SARS-CoV-2 Omicron variant (B.1.1.529) [Internet]. 2021. Available from: https://www.who.int/news-room/articles-detail/who-advice-for-international-traffic-in-relation-to-the-sars-cov-2-omicron-variant
https://doi.org/10.12659/msm.936199
World Health Organization. The WHO Global Clinical Platform for COVID-19 [Internet]. 2021 [cited 2021 Dec 10]. Available from: https://www.who.int/teams/health-care-readiness-clinical-unit/covid-19/data-platform
https://doi.org/10.2471/blt.21.285550
World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection: Interim guidance, 06 October 2021 [Internet]. 2021 [cited 2021 Dec 10]. Available from: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays
https://doi.org/10.32388/s44y1q
Zhang L, Li Q, Liang Z, Li T, Liu S, Cui Q, et al. The significant immune escape of pseudotyped SARS-CoV-2 Variant Omicron. Emerg Microbes Infect. 2021 Dec 10;1–11.
https://doi.org/10.1080/22221751.2021.2017757
World Health Organization. Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021 [Internet]. [cited 2021 Dec 10]. Available from: https://www.who.int/publications/i/item/WHO_2019-nCoV_surveillance_variants
Downloads
Published
How to Cite
License
Copyright (c) 2022 Indian Journal of Community Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.